Purpose
The diagnosis and treatment of high-grade gliomas is a difficult task due to their tendency to continued growth. It is often accompanied by the impaired blood-brain barrier (1, 2). The combined approach in glioblastoma's treatment, including surgery, radiation, and chemotherapy, complicates its diagnosis even more (3). The destruction of the blood-brain barrier after treatment is also noted. So, the accumulation of a contrast agent in all cases makes it difficult to differentiate the residual tumor tissue against the background of postoperative and radiation injuries in...
Methods and materials
We measured the CBF value in presumed tumor tissue in patients with histologically verified glioblastoma (GRADE IV) right after surgical resection before radiotherapy and repeated 3-4 months after radiotherapy. 63 patients were examined initially – 36 men (57,1%) and 27 women (42,9%). The average age of patients was 56,8±11,1 years (min- 31 years, max- 80 years), there were no significant differences in age between the examined men and women (56.2 ± 11.5 years in men, 57.5 ± 10.9 years in women, p = 0.52).
MRI...
Results
All patients were divided into 2 groups according to CBF value on the first visit.
1st group: 41 patients (65.1%) with high level of perfusion in ROI 1 (in presumed tumor tissue), the average CBF there was 135,4±41,3 ml / 100 g / min (min - 73.9, max - 255.9). After radiotherapy 20 patients returned. 15 of them (75%) had decreased CBF about 40-60% in previous tumor area (65,7±35,3 compared 138,8±33,8 ml / 100 g / min on first visit).Fig. 2,Fig. 3,Fig. 4
But there...
Conclusion
In our study we showed the evaluation of CBF is enough to identify residual tumor tissue against the background of postoperative and radiation injuries in the brain. So we can conclude that ASL perfusion in addition to contrast MRI- methods increase the possibility of differential diagnosis of brain changes in patients with glioblastoma in different periods after radiotherapy.
Personal information and conflict of interest
M. Bunak; Moscow/RU - nothing to disclose M. Vishnyakova; Moscow/RU - nothing to disclose A. S. Abramenko; Moscow/RU - nothing to disclose G. V. Chermensky; Moscow/RU - nothing to disclose
References
1. Luiz Gustavo Dubois, Loraine Campanati, Cassia Righy, Isabella D’Andrea-Meira, Tania Cristina Leite de Sampaio e Spohr.Gliomas and the vascular fragility of the blood brain barrier. Front. Cell. Neurosci., 12 December 2014
2. Huang AP, Tsai JC, Kuo LT, Lee CW, Lai HS, Tsai LK, Huang SJ, Chen CM, Chen YS, Chuang HY, Wintermark M. Clinical application of perfusion computed tomography in neurosurgery. J Neurosurg 120: 473 488, 2014
3. Chen Y., Trotti A., Coleman C. et al. Adverse event reporting and developments in radiation...